These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


162 related items for PubMed ID: 17204908

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Comparison of midregional pro-atrial natriuretic peptide with N-terminal pro-B-type natriuretic peptide in predicting survival in patients with chronic heart failure.
    von Haehling S, Jankowska EA, Morgenthaler NG, Vassanelli C, Zanolla L, Rozentryt P, Filippatos GS, Doehner W, Koehler F, Papassotiriou J, Kremastinos DT, Banasiak W, Struck J, Ponikowski P, Bergmann A, Anker SD.
    J Am Coll Cardiol; 2007 Nov 13; 50(20):1973-80. PubMed ID: 17996563
    [Abstract] [Full Text] [Related]

  • 26. Effects of myocardial fibrosis and ventricular dyssynchrony on response to therapy in new-presentation idiopathic dilated cardiomyopathy: insights from cardiovascular magnetic resonance and echocardiography.
    Leong DP, Chakrabarty A, Shipp N, Molaee P, Madsen PL, Joerg L, Sullivan T, Worthley SG, De Pasquale CG, Sanders P, Selvanayagam JB.
    Eur Heart J; 2012 Mar 13; 33(5):640-8. PubMed ID: 22048681
    [Abstract] [Full Text] [Related]

  • 27. In patients with severe systolic dysfunction, only brain natriuretic peptide is related to diastolic restrictive pattern.
    Catuzzo B, Ciancamerla F, Bobbio M, Longo M, Trevi GP.
    J Card Fail; 2003 Aug 13; 9(4):303-10. PubMed ID: 13680551
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Comparison of treatment effects of bevantolol and metoprolol on cardiac function and natriuretic peptides in patients with dilated cardiomyopathy.
    Hara Y, Hamada M, Ohtsuka T, Ogimoto A, Saeki H, Matsunaka T, Suzuki J, Shigematsu Y.
    Heart Vessels; 2002 Dec 13; 17(2):53-6. PubMed ID: 12541094
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Effect of left ventricular reverse remodeling on long-term prognosis after therapy with angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers and β blockers in patients with idiopathic dilated cardiomyopathy.
    Hoshikawa E, Matsumura Y, Kubo T, Okawa M, Yamasaki N, Kitaoka H, Furuno T, Takata J, Doi YL.
    Am J Cardiol; 2011 Apr 01; 107(7):1065-70. PubMed ID: 21296328
    [Abstract] [Full Text] [Related]

  • 32. An appropriate indication for the initiation of beta-blocker therapy in dilated cardiomyopathy.
    Morooka T, Inoue T, Kotooka N, Fujimatsu D, Komatsu A, Uchida F, Yoshida K, Hashimoto S, Hikichi Y, Kato T, Node K.
    Cardiology; 2006 Apr 01; 105(1):61-6. PubMed ID: 16272814
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Beta blockers prevent correlation of plasma ACE2 activity with echocardiographic parameters in patients with idiopathic dilated cardiomyopathy.
    Wang Y, Moreira Mda C, Heringer-Walther S, Schultheiss HP, Siems WE, Wessel N, Walther T.
    J Cardiovasc Pharmacol; 2015 Jan 01; 65(1):8-12. PubMed ID: 25165996
    [Abstract] [Full Text] [Related]

  • 37. Circulating C-type natriuretic peptide is increased in orthotopic cardiac transplant recipients and associated with cardiac allograft vasculopathy.
    Buckley MG, Jenkins GH, Mitchell AG, Yacoub MH, Singer DR.
    Clin Sci (Lond); 2000 Nov 01; 99(5):467-72. PubMed ID: 11052928
    [Abstract] [Full Text] [Related]

  • 38. Plasma brain natriuretic peptide level as a biochemical marker of morbidity and mortality in patients with asymptomatic or minimally symptomatic left ventricular dysfunction. Comparison with plasma angiotensin II and endothelin-1.
    Tsutamoto T, Wada A, Maeda K, Hisanaga T, Mabuchi N, Hayashi M, Ohnishi M, Sawaki M, Fujii M, Horie H, Sugimoto Y, Kinoshita M.
    Eur Heart J; 1999 Dec 01; 20(24):1799-807. PubMed ID: 10581138
    [Abstract] [Full Text] [Related]

  • 39. Effects of carvedilol on plasma B-type natriuretic peptide concentration and symptoms in patients with heart failure and preserved ejection fraction.
    Takeda Y, Fukutomi T, Suzuki S, Yamamoto K, Ogata M, Kondo H, Sugiura M, Shigeyama J, Itoh M.
    Am J Cardiol; 2004 Aug 15; 94(4):448-53. PubMed ID: 15325927
    [Abstract] [Full Text] [Related]

  • 40. Marked improvement in left ventricular ejection fraction during long-term beta-blockade in patients with chronic heart failure: clinical correlates and prognostic significance.
    Metra M, Nodari S, Parrinello G, Giubbini R, Manca C, Dei Cas L.
    Am Heart J; 2003 Feb 15; 145(2):292-9. PubMed ID: 12595847
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 9.